About QMENTA
QMENTA is a healthcare AI company that provides a cloud-based software platform for managing and analyzing medical imaging data, primarily for clinical trials and research, with FDA 510(k) clearance. Their core product, the QMENTA Imaging Hub, integrates five components: Imaging Cloud, Smart Uploader, AI Imaging Biomarkers (with over 50 algorithms), Central Review with adjudication tools, and Imaging EDC with query management and reporting. This comprehensive platform is designed to streamline imaging workflows, from multi-site data harmonization and quality control to AI biomarker analysis and central review, all within a single, regulated environment.
QMENTA’s platform is particularly focused on neuroimaging, offering a biomarker catalog heavily weighted toward neurological disease areas such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, other neurodegenerative conditions, and rare diseases. It supports the entire neuroimaging workflow, providing tools for diagnosis, prognosis, monitoring, and decision support for experts and physicians. The platform aims to accelerate drug development and improve clinical care for brain diseases by providing a governed data layer that makes imaging data reliable, usable, and submission-ready, eliminating operational delays. QMENTA’s solutions are built with regulatory compliance in mind, adhering to standards such as FDA 21 CFR Part 11 & 820, Annex 11, GDPR, IEC 62304, ISO 13485:2016, and HIPAA.
Focus Areas
Business Intelligence
| Technology | cloud-native, AI orchestration platform, Imaging Cloud, Smart Uploader, AI Imaging Biomarkers, Central Review, Imaging EDC, SDK |
What Physicians Need to Know
For physicians, QMENTA offers an easy-to-use neuroimaging software solution that simplifies neurological evaluations and improves diagnosis confidence and accuracy. The platform provides access to a world-leading catalog of AI biomarker tools that offer unique insights into the brain, accentuating changes to tissue and highlighting damage or hyperintensities in 3D and color. This can lead to significant time savings by automating advanced image analysis and aiding in treatment decision-making by providing consistent, quantified insights into brain features and changes. The platform's regulatory compliance (FDA 510(k) clearance) means that the AI-powered imaging management and analysis environment is a regulated medical product, reducing the validation burden for physicians and ensuring trustworthy results. QMENTA's tools can help overcome challenges associated with manual analysis, subjective interpretation, and delays in effective treatment.
QMENTA's platform is designed to be vendor-neutral, supporting integration with any DICOM-compliant system, including those from major vendors like GE HealthCare, Siemens Healthineers, Philips, Canon, and United Imaging. It also integrates industry-standard third-party algorithms like FSL and FreeSurfer into its biomarker marketplace. The platform's architecture allows for seamless integration into existing medical imaging workflows, supporting various imaging modalities such as MRI, CT, and PET, and a wide range of medical imaging file formats including DICOM, NIFTI, and Analyze.
What the Web Says
QMENTA is a cloud-native medical imaging AI platform primarily used for regulated clinical trials and research in neuroscience. Reviewers highlight its ease of use, flexibility, and robust security features for handling complex neuroimaging data. The platform is compliant with various regulatory standards, including FDA 21 CFR Part 11, HIPAA, GDPR, and ISO 13485. While there are limited reviews available, the overall sentiment is positive, focusing on the product's capabilities rather than employer experiences.
Overall: PositiveStrengths
- Easy to use and intuitive interface for neuroimaging analysis.
- Provides flexibility and customization for data analysis and visualization.
- Highly secure cloud environment with tracked activity for data security.
- Compliant with major regulatory standards (FDA 21 CFR Part 11, HIPAA, GDPR, ISO 13485).
- Offers advanced AI tools for imaging biomarkers and quality assurance.
- Streamlines the entire imaging workflow for clinical trials, from data ingestion to regulatory submission.
Limitations
- Limited number of public reviews available on platforms like G2 and Capterra.
- Lack of flexibility in customizing the workspace, which can hinder user experience.
- Cloud-based solution requires setting up specific ports and authorization, which can involve initial paperwork.
- No specific employer reviews found on Glassdoor or similar platforms.
- No reviewer feedback on customer support quality is available.
Based on reviews from: G2, Capterra, Reddit, QMENTA Website
Last updated: 2026-10-18
Videos
News, demos, and interviews about QMENTA.
Videos load interactively. If none appear, search YouTube for QMENTA →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded QMENTA.
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]